Tag: IoT

RTLS Can Enhance the Patient Experience, Staff Safety, and Workflow Operations in 2023

RTLS Can Enhance the Patient Experience, Staff Safety, and Workflow Operations in 2023

HIT Consultant

Scott Hondros, MHA, SCPM, VP of Professional Services at CenTrakAlthough the healthcare industry has shown significant resilience, the byproduct of the pandemic has amplified staff stressors across all operational and clinical roles. In a study conducted in 2022, more than one-third (34%) of the participating registered nurses (RN) stated that it was likely they would leave bedside nursing by the end of the year. Almost half (44%) cited both burnout and high-stress environments as their main reasons to retire or pursue other careers. As staff shortages increase, so do workloads. Forty-three percent of the nurses that responded to Hospital IQ’s recent survey…

Continue Reading
GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’

GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’

MedCity News

Vir Biotechnology’s Covid-19 research may yield more drugs and perhaps a vaccine, but no longer with the financial support of GSK. The collaboration agreement the two companies struck up in the early days of the pandemic has been amended, leaving Vir to either find another partner or continue its coronavirus research on its own.
The alliance did successfully develop the Covid-19 drug sotrovimab. GSK and Vir will continue to share responsibilities for that drug, which is available under the brand name Xevudy in more than 40 countries. The U.S. is no longer one of them. Last April, the FDA withdrew emergency authorization…

Continue Reading
Adverse Survival Signal Leads G1 to Stop Pivotal Test in Colorectal Cancer

Adverse Survival Signal Leads G1 to Stop Pivotal Test in Colorectal Cancer

MedCity News

G1 Therapeutics’ approach to cancer does not kill tumors. Instead, the biotech’s drug, trilaciclib, protects bone marrow from the damaging effects of chemotherapy, reducing the duration and severity of the problems that can limit the use of this cancer treatment. Since trilaciclib’s initial approval insmall cell lung cancer, G1 has pursued more clinical trials that could support expanding the drug to other cancers. Colorectal cancer will no longer be one of them.
On Monday, G1 reported preliminary data showing that the placebo group outperformed the trilaciclib arm in helping patients live longer. G1 said it has decided to stop the colorectal cancer…

Continue Reading
Epic remains Best in KLAS for overall software suite for 13th year

Epic remains Best in KLAS for overall software suite for 13th year

Healthcare IT news

In addition to winning overall, Epic was named top Overall Physician Practice Vendor based on provider feedback in this year’s Best in KLAS awards. The health IT giant also earned plaudits in 13 other categories, the research firm announced Wednesday.Of note, Impact Advisors and Nordic are tied as co-winners of the Overall IT Services category. 
Impact Advisors also took top placements in ERP Implementation Leadership, Financial Improvement Consulting and Security & Privacy Consulting Services categories while Nordic won for HIT Core Clinical Implementation Leadership.
The KLAS announcement noted that Nordic also scored above 90 in four separate services segments, which is detailed in 2023…

Continue Reading
UChicago to launch accelerator for AI and data science companies

UChicago to launch accelerator for AI and data science companies

Healthcare IT news

The University of Chicago this week announced the creation of Transform, an accelerator for early-stage technology companies focused on data science and artificial intelligence.WHY IT MATTERSThe new program – which is part of the Deep Tech Ventures initiative at the UChicago’s Polsky Center for Entrepreneurship and Innovation – aims to offer a wide array of support to startups: access to business and technical training, industry mentorship, venture capital connections, and funding opportunities
Transform is seeking two cohorts of as many as 10 companies each. Candidates should be focused on information technologies and data science: AI and machine learning, data engineering, analytics and…

Continue Reading